Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation Plans and Awards

v3.2.0.727
Stock-based Compensation Plans and Awards
6 Months Ended
Jun. 30, 2015
Stock-based Compensation Plans and Awards [Abstract]  
Stock-based Compensation Plans and Awards

10. Stock-based Compensation Plans and Awards

 

In January 2014, and prior to the Merger, the Board of Directors and a majority of the stockholders adopted the 2014 Plan that allowed for the issuance of 14,410,000 shares of common stock. Options previously issued under the Ekso Bionics 2007 Equity Incentive Plan were converted into options to purchase an aggregate of 7,602,408 shares of the Company's common stock under the 2014 Plan. On June 10, 2015, the 2014 Plan was amended and restated by the stockholders to increase the maximum number of shares by 11,590,000 shares to an aggregate of 26,000,000 shares of common stock available for issuance under the 2014 Plan. As of June 30, 2015, there were 11,767,633 shares available for future awards.


Under the terms of the 2014 Plan, the Board of Directors may award stock, options, or similar rights having either a fixed or variable price related to the fair market value of the shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions, or any other security with the value derived from the value of the shares. Such awards include stock options, restricted stock, restricted stock units, stock appreciation rights and dividend equivalent rights.

 

The Board of Directors may grant stock options under the 2014 Plan at a price of not less than 100% of the fair market value of our common stock on the date the option is granted. Incentive stock options granted to employees who, on the date of grant, own stock representing more than 10% of the voting power of all of our classes of stock, are granted at an exercise price of not less than 110% of the fair market value of our common stock. The maximum term of incentive stock options granted to employees who, on the date of grant, own stock possessing more than 10% of the voting power of all our classes of stock, may not exceed five years. The maximum term of an incentive stock option granted to any other participant may not exceed ten years. Subject to the limitations discussed above, the Board of Directors determines the term and exercise or purchase price of other awards granted under the 2014 Plan. The Board of Directors also determines the terms and conditions of awards, including the vesting schedule and any forfeiture provisions. Options granted under the 2014 Plan may vest upon the passage of time, generally four years, or upon the attainment of certain performance criteria established by the Board of Directors. We may from time to time grant options to purchase common stock to non-employees for advisory and consulting services. Pursuant to ASC 505-50, Equity-Based Payments to Non-Employees, we periodically re-measure the fair value of these stock options using the Black-Scholes option pricing model and recognize expense ratably over the vesting period of each stock option award. Upon exercise of an option, it is the Company's policy to issue new shares of common stock.


The following table summarizes information about the Company's stock options outstanding at June 30, 2015, and activity during the six-month period then ended:

 

    Weighted-        
    Average           
Weighted-     Remaining     Aggregate
Stock Average     Contractual     Intrinsic
    Awards     Exercise Price     Life (Years)     Value
Balance as of December 31, 2014     10,791,081     $ 0.79                  
Options granted     3,184,000     $ 1.40                  
Options exercised     (697,356 )   $ 0.55                  
Options forfeited     (40,507 )   $ 0.57                  
Options cancelled     (10,126   $ 1.74                  
Balance as of June 30, 2015     13,227,092     $ 0.96       7.86     $ 4,197  
Vested and expected to vest at June 30, 2015     12,118,042     $ 0.92       7.71     $ 4,131  
Exercisable as of June 30, 2015     5,970,959     $ 0.60       6.23     $ 3,451  

 

Of the 697,356 shares exercised, 535,404 were on a cashless basis for which the Company did not receive any proceeds, but instead withheld 243,647 shares from the option holders exercising such award to cover the exercise amount.


As of June 30, 2015, total unrecognized compensation cost related to unvested stock options was $5,386. This amount is expected to be recognized as stock-based compensation expense in the Company's Condensed Consolidated Statements of Operations over the remaining weighted average vesting period of 3.09 years.

 

The per-share fair value of each stock option was determined on the date of grant using the Black-Scholes option pricing model using the following assumptions:

 

  Three months ended June 30,
Six months ended June 30,
  2015     2014
2015
2014
           
         
Dividend yield                  
Risk-free interest rate     1.44% - 2.34       1.90% - 2.61%
  1.41% - 2.34%       1.74% - 2.67%  
Expected term (in years)     6-10        6-8
  6-10       6-10  
Volatility     73% - 74       66%     73% - 74%       66%  

 

Total stock-based compensation expense related to options granted to employees and non-employees was included in the Condensed Consolidated Statements of Operations as follows:

 

  Three months ended June 30,   Six months ended June 30,  
  2015 2014   2015     2014       
Sales and marketing $ 161 $ 150   $ 292     $ 251  
Research and development 108 21     162       90  
General and administrative 174 155       337       352  
  $ 443
$ 326     $ 791     $ 693